CapsoVision reports second quarter 2026 financial results
Revenue grew 10% to $3.6M, AI Highlights launched in EU, FDA clearance expected Q3.
See the latest news and media coverage for CapsoVision. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical device company specializing in gastrointestinal diagnostic imaging
capsovision.comLast updated
In short: CapsoVision reported 10% revenue growth for Q2 2026 and launched AI Highlights in the EU while awaiting U.S. regulatory clearance.
Revenue grew 10% to $3.6M, AI Highlights launched in EU, FDA clearance expected Q3.
The company will host a conference call and webcast at 1:30 pm PT on August 13 to discuss the results and provide a corporate update.
A conference call and webcast will follow at 1:30 pm PT that day.
Revenue grew 13% in Q4 and 15% for the year, with new accounts up 16% and 21% respectively.
Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. to establish an at-the-market program for issuing up to $100 million of common stock, enabling...
Revenue up 10% with AI Highlights commercial launch in EU, but margin compression and FDA delays temper outlook.
"The second quarter represented another period of steady progress for CapsoVision as we continued executing our commercial strategy while advancing several important initiatives across our...
CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the Company will release ...
Track CapsoVision and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.